Eric Kong

Eric Kong has over 11 years of work experience in the field of chemistry analysis development. Eric spent 9 years at Novartis where they worked in the process R&D and production of APIs for GLP/IND/NDA/PPQ campaign projects. Eric also had 2 years of experience in the overall operation of a kilo-lab, overseeing safety, quality, and budget. In this role, they were responsible for all GLP campaign product production and global supply within the company. At STA Pharmaceutical, they worked as an Associate Director in CMC Project Management, where they managed and coordinated projects across multiple sites and departments. Their responsibilities included pre-formulation & solid state development, formulation process R&D, and GMP production & commercial production. Eric was also involved in new drug applications in China, the United States, and the European Union, supporting a total of 19 projects and completing 5 project submissions. Eric Kong is currently working as the CMC Director at AnHeart Therapeutics.

Eric Kong attended Shenyang Pharmaceutical University from 2005 to 2008, where they obtained a Bachelor's degree in Pharmaceutical Chemistry.